Antiviral Lead Identification to Treat Filovirus Infections
治疗丝状病毒感染的抗病毒先导药物鉴定
基本信息
- 批准号:10453443
- 负责人:
- 金额:$ 63.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-12 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAnimal Disease ModelsAnimal ModelAntiviral AgentsAntiviral TherapyBindingBiochemicalBiochemistryBiological AssayBiological AvailabilityBiomedical ResearchBostonCategory A pathogenCell modelCellsCellular AssayChemicalsChemistryDataDendritic CellsDevelopmentDiseaseDoseDrug KineticsDrug TargetingEbolaEbola virusEndosomesFiloviridae InfectionsFilovirusFormulationFunding MechanismsGoalsHepatocyteHumanIn VitroInfectionIntegration Host FactorsInterventionIon ChannelLactonesLeadMarburgvirusMeasuresMetabolicModelingMolecularMusNational Institute of Allergy and Infectious DiseaseNatural ProductsOralOutcomePathway interactionsPharmaceutical ChemistryPharmaceutical PreparationsPharmaceutical TechnologyPharmacologic SubstancePharmacologyPhenotypePlasmaPopulationPrimary InfectionProcessPropertyPumpRelative RisksResearchResearch InstituteResearch PersonnelRetroviridaeRiskSafetySelection CriteriaSeriesSiteTestingTexasTherapeuticTissuesToxic effectToxicologyTranslatingTranslationsUniversitiesValidationVesicleViralVirusVirus Replicationanalogantagonistanti-viral efficacyantiviral drug developmentbasebiosafety level 4 facilitydesigndrug actionefficacy studyefficacy testingimprovedin vitro testingin vivoin vivo Modelinhibitorinsightlate endosomelead candidatemacrophagemembermouse modelnonhuman primatenovel strategiesnovel therapeuticspathogenic viruspre-clinicalpreventsafety testingsmall moleculevacuolar H+-ATPaseviral entry inhibitor
项目摘要
A research team from Purdue University and Texas Biomedical Research Institute is in pursuit of important new approaches to validate the host V-ATPase. The project goal to define antiviral drug leads for diseases caused by Ebola and Marburg filoviruses. Many viral pathogens bind to specific factors of host cells to penetrate the plasma member inside vesicles called endosomes. However, entry of the virus to the host cells requires escape from these vesicles. A majority of these viruses utilize the low pH of late endosomes to trigger the final steps in viral entry. Since the acidification of endosomes depends on vacuolar H(+)-ATPases (V-ATPases), inhibiting this pump interferes with entry of a wide range of viruses. Thus, the host V-ATPase represents a truly broad-spectrum target for antiviral drugs. While feasible, there are challenges for developing antiviral drugs that targets host factors like V-ATPase because of the potential risk of toxicity to non-infected cells and tissues. The approach used in this project directly addresses this challenge which will apply discovery and pharmaceutical technologies to achieve selectivity of drug action. The project team brings significant expertise to the challenges for discovery and development of host-targeted antiviral therapeutics. Efforts will integrate chemistry and biochemistry of natural-product V-ATPase inhibitors, viral-host entry pathways, Ebola and Marburg animal disease models in BSL4 facility, in vitro and in vivo ADME-pharmacokinetics, and toxicology. Currently, there is a lack of suitable in vivo chemical probes available to test safety and efficacy of pharmaceutical interventions targeting V-ATPase. The objectives for this five-year project are to: a) qualify a class of selective chemical inhibitors for V-ATPase suitable for in vivo antiviral efficacy testing, and b) identify a new drug lead candidate targeting V-ATPase function during the viral entry process for Ebola and Marburg filoviruses. These complementary objectives will impact the prospects and precise strategy for developing antiviral therapies to treat unmet needs.
来自普渡大学和德克萨斯生物医学研究所的一个研究小组正在寻求重要的新方法来验证宿主v - atp酶。该项目的目标是确定由埃博拉和马尔堡丝状病毒引起的疾病的抗病毒药物先导物。许多病毒病原体与宿主细胞的特定因子结合,穿透称为内体的囊泡内的浆体成员。然而,病毒进入宿主细胞需要逃离这些囊泡。这些病毒中的大多数利用后期核内体的低pH值来触发病毒进入的最后步骤。由于内体的酸化取决于空泡H(+)- atp酶(v - atp酶),抑制这种泵会干扰多种病毒的进入。因此,宿主v - atp酶代表了抗病毒药物的真正广谱靶标。虽然可行,但开发针对v - atp酶等宿主因子的抗病毒药物存在挑战,因为对未感染的细胞和组织有潜在的毒性风险。本项目中使用的方法直接解决了这一挑战,它将应用发现和制药技术来实现药物作用的选择性。项目团队为发现和开发针对宿主的抗病毒治疗带来了重要的专业知识。他们将努力整合天然产物v - atp酶抑制剂的化学和生物化学、病毒宿主进入途径、BSL4设施中的埃博拉和马尔堡动物疾病模型、体外和体内adme药代动力学和毒理学。目前,缺乏合适的体内化学探针来检测针对v - atp酶的药物干预的安全性和有效性。这个为期五年的项目的目标是:a)确定一类适合体内抗病毒功效测试的V-ATPase选择性化学抑制剂,以及b)确定一种新的候选药物,靶向埃博拉和马尔堡丝状病毒在病毒进入过程中的V-ATPase功能。这些互补的目标将影响开发抗病毒疗法以治疗未满足需求的前景和精确策略。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT A DAVEY其他文献
ROBERT A DAVEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT A DAVEY', 18)}}的其他基金
Antiviral Lead Identification to Treat Filovirus Infections
治疗丝状病毒感染的抗病毒先导药物鉴定
- 批准号:
10217981 - 财政年份:2019
- 资助金额:
$ 63.7万 - 项目类别:
Antiviral Lead Identification to Treat Filovirus Infections
治疗丝状病毒感染的抗病毒先导药物鉴定
- 批准号:
9765787 - 财政年份:2019
- 资助金额:
$ 63.7万 - 项目类别:
High Biocontainment (BSL4/ABSL4) core for replication competent virus work
用于复制病毒工作的高生物防护 (BSL4/ABSL4) 核心
- 批准号:
10555054 - 财政年份:2016
- 资助金额:
$ 63.7万 - 项目类别:
Roles of host factor protein subnetworks in regulating steps of filovirus infection
宿主因子蛋白亚网在丝状病毒感染调节步骤中的作用
- 批准号:
10555057 - 财政年份:2016
- 资助金额:
$ 63.7万 - 项目类别:
Emerging virus-host cell protein interaction networks
新兴的病毒-宿主细胞蛋白质相互作用网络
- 批准号:
8964885 - 财政年份:2015
- 资助金额:
$ 63.7万 - 项目类别:
Novel broad spectrum inhibitors of filovirus infection
丝状病毒感染的新型广谱抑制剂
- 批准号:
8806955 - 财政年份:2015
- 资助金额:
$ 63.7万 - 项目类别:
Emerging virus-host cell protein interaction networks
新兴的病毒-宿主细胞蛋白质相互作用网络
- 批准号:
9063092 - 财政年份:2015
- 资助金额:
$ 63.7万 - 项目类别:
Novel broad spectrum inhibitors of filovirus infection
丝状病毒感染的新型广谱抑制剂
- 批准号:
9131611 - 财政年份:2015
- 资助金额:
$ 63.7万 - 项目类别:
HTS for Filo- and Arena-virus Entry Mechanisms
用于丝状病毒和沙粒病毒进入机制的 HTS
- 批准号:
7845149 - 财政年份:2009
- 资助金额:
$ 63.7万 - 项目类别:
Discovery & Characterization of Filo-. Arena -and Alpha Virus Entry Inhibitors
发现
- 批准号:
7676506 - 财政年份:2009
- 资助金额:
$ 63.7万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 63.7万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 63.7万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 63.7万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 63.7万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 63.7万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 63.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 63.7万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 63.7万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 63.7万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 63.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists